Načítá se...
Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist’s point of view
Breast conserving therapy (BCT) is currently a recognized alternative to mastectomy for early BC patients. However, the therapeutic index of BCT was considered controversial for decades in BRCA1/2 mutation carriers. The aim of the present review was to investigate the outcome of mutation carriers un...
Uloženo v:
| Vydáno v: | Br J Radiol |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The British Institute of Radiology.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6580916/ https://ncbi.nlm.nih.gov/pubmed/30810334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1259/bjr.20170657 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|